Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

Reinier Smit; Rob J. van Marum; Nathalie C. Péquériaux; Daan A. Hollander; Michiel W.P. Bleeker; Yasamin Latify; Walter A. Hermens; H. J. Derijks

doi:https://doi.org/10.1007/s00228-017-2339-7

Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

Reinier Smit, Rob J. van Marum, Nathalie C. Péquériaux, Daan A. Hollander, Michiel W.P. Bleeker, Yasamin Latify, Walter A. Hermens, H. J. Derijks

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	139-140
Number of pages	2
Journal	European journal of clinical pharmacology
Volume	74
Issue number	1
DOIs	https://doi.org/10.1007/s00228-017-2339-7
Publication status	Published - 1 Jan 2018

Access to Document

https://doi.org/10.1007/s00228-017-2339-7

Cite this

@article{2ec2b353f7f741ee96e958604732747a,

title = "Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin",

author = "Reinier Smit and {van Marum}, {Rob J.} and P{\'e}qu{\'e}riaux, {Nathalie C.} and Hollander, {Daan A.} and Bleeker, {Michiel W.P.} and Yasamin Latify and Hermens, {Walter A.} and Derijks, {H. J.}",

year = "2018",

month = jan,

day = "1",

doi = "https://doi.org/10.1007/s00228-017-2339-7",

language = "English",

volume = "74",

pages = "139--140",

journal = "European journal of clinical pharmacology",

issn = "0031-6970",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

AU - Smit, Reinier

AU - van Marum, Rob J.

AU - Péquériaux, Nathalie C.

AU - Hollander, Daan A.

AU - Bleeker, Michiel W.P.

AU - Latify, Yasamin

AU - Hermens, Walter A.

AU - Derijks, H. J.

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85030105649&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s00228-017-2339-7

DO - https://doi.org/10.1007/s00228-017-2339-7

M3 - Article

C2 - 28956088

SN - 0031-6970

VL - 74

SP - 139

EP - 140

JO - European journal of clinical pharmacology

JF - European journal of clinical pharmacology

IS - 1

ER -

Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

Access to Document

Other files and links

Cite this